However, long-term treatment with CSF-1R inhibitors resulted in accumulation of IL4 released from other TME cell types which stimulated TAMs to secrete IGF-1 and conversely sustained the survival and growth of glioma cells. This evidence concerns the gene CSF1R and central nervous system cancer.